Annual CFF
$5600.00
-$54.70 K-90.71%
December 1, 2022
Summary
- As of March 13, 2025, CERO annual cash flow from financing activities is $5600.00, with the most recent change of -$54.70 thousand (-90.71%) on December 1, 2022.
- During the last 3 years, CERO annual CFF has fallen by -$54.70 thousand (-90.71%).
- CERO annual CFF is now -90.71% below its all-time high of $60.30 thousand, reached on December 1, 2021.
Performance
CERO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
N/A
September 1, 2024
Summary
- CERO quarterly cash flow from financing activities is not available.
Performance
CERO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
September 1, 2024
Summary
- CERO TTM cash flow from financing activities is not available.
Performance
CERO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CERO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -90.7% | - | - |
| 3 y3 years | -90.7% | - | - |
| 5 y5 years | -90.7% | - | - |
CERO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.7% | at low | ||||
| 5 y | 5-year | -90.7% | at low | ||||
| alltime | all time | -90.7% | at low |
CERo Therapeutics Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $0.00(-100.0%) | $571.70 K(0.0%) |
| Jun 2023 | - | $566.50 K(>+9900.0%) | $571.70 K(>+9900.0%) |
| Mar 2023 | - | $5200.00 | $5200.00 |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $5600.00(-90.7%) | - | - |
| Mar 2022 | - | $0.00 | $0.00 |
| Dec 2021 | $60.30 K | - | - |
FAQ
- What is CERo Therapeutics Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings annual CFF year-on-year change?
- What is the all time high quarterly CFF for CERo Therapeutics Holdings?
- What is the all time high TTM CFF for CERo Therapeutics Holdings?
What is CERo Therapeutics Holdings annual cash flow from financing activities?
The current annual CFF of CERO is $5600.00
What is the all time high annual CFF for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high annual cash flow from financing activities is $60.30 K
What is CERo Therapeutics Holdings annual CFF year-on-year change?
Over the past year, CERO annual cash flow from financing activities has changed by -$54.70 K (-90.71%)
What is the all time high quarterly CFF for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high quarterly cash flow from financing activities is $566.50 K
What is the all time high TTM CFF for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high TTM cash flow from financing activities is $571.70 K